Related Experiment Video
Updated: May 1, 2026

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
Published on: April 24, 2021
One siRNA pool targeting the λ constant region stops λ light-chain production and causes terminal endoplasmic
Ping Zhou1, Xun Ma1, Lakshmanan Iyer2
1Tufts Medical Center, Boston, MA; and.
Abstract:
In systemic light-chain amyloidosis, λ light chains produced by clonal plasma cells cause organ damage and early death. In pursuit of novel therapy, we developed 1 pool of short interfering RNA (siRNA) targeting the constant region of λ light chains that substantially and promptly reduces λ-light-chain production and secretion by human plasma cells regardless of sequence diversity. In clones producing intact immunoglobulin G (IgG) λ antibodies (containing paired heavy and light chains), the secretion of intact antibodies is reduced, and all 3 branches of the unfolded protein response are activated by accumulation of unpaired IgG heavy chains in the endoplasmic reticulum (ER). Moreover, an ER stress response can then become terminal with effector caspase activity mediated in part by the transcription of the Bcl-2 homology 3 domain only family member NOXA. This pool of siRNA can be used to reduce pathological λ-light-chain production and cause apoptosis in human plasma cells making intact IgGλ antibodies.
Insights
Short interfering RNA (siRNA) targeting lambda light chains offers a novel therapy for systemic light-chain amyloidosis. This approach reduces pathological lambda light chain production and induces apoptosis in plasma cells.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Systemic light-chain amyloidosis is caused by abnormal lambda light chains from clonal plasma cells, leading to organ damage and mortality.
- Current treatments for light-chain amyloidosis have limitations, necessitating novel therapeutic strategies.
Purpose of the Study:
- To develop and evaluate a novel therapeutic approach using short interfering RNA (siRNA) to target and reduce pathological lambda light chain production.
- To investigate the effects of siRNA-mediated lambda light chain reduction on plasma cells and the unfolded protein response.
Main Methods:
- Development of a pool of siRNA targeting the constant region of lambda light chains.
- Assessment of siRNA efficacy in reducing lambda light chain production and secretion in human plasma cells.
- Analysis of the unfolded protein response and endoplasmic reticulum stress markers in response to siRNA treatment.
- Evaluation of apoptosis induction in plasma cells producing intact immunoglobulin G (IgG) lambda antibodies.
Main Results:
- The developed siRNA pool substantially and promptly reduced lambda light chain production and secretion by human plasma cells.
- In cells producing intact IgG lambda antibodies, siRNA treatment led to reduced antibody secretion and activation of all three branches of the unfolded protein response.
- Accumulation of unpaired IgG heavy chains in the endoplasmic reticulum triggered an ER stress response, leading to terminal apoptosis mediated by NOXA.
Conclusions:
- A pool of siRNA targeting lambda light chains is a promising therapeutic strategy for systemic light-chain amyloidosis.
- This siRNA therapy effectively reduces pathological lambda light chain production and induces apoptosis in malignant plasma cells.
- The findings highlight the potential of targeting lambda light chains to treat light-chain amyloidosis and related plasma cell disorders.
More Related Videos
Related Concept Videos
Regulation of the Unfolded Protein Response
Directing Proteins to the Rough Endoplasmic Reticulum
Stringent Response in E. coli
The Unfolded Protein Response
Post-translational Translocation of Proteins to the RER
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
Cotranslational Protein Translocation
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...

